Advances in drug therapy for inflammatory bowel disease.
about
Medical management of inflammatory bowel disease in the new millennium.Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group.Medical therapy in Crohn's disease.Molecular mechanism of methotrexate action in inflammation.New developments in the pharmacotherapy of inflammatory bowel disease.Mesalamine-related lung disease: clinical, radiographic, and pathologic manifestations.A diagnostic approach to 'difficult' asthma.Noradrenaline transmission reducing drugs may protect against a broad range of diseases.Immunomodulator therapy in inflammatory bowel disease.Treatment of distal ulcerative colitis with nonsystemic corticosteroid enemas.Asymptomatic presentation of mesalamine-induced lung injury in an adolescent with Crohn diseaseEffect of drugs on colonic eicosanoid accumulation in active ulcerative colitis.A prospective randomized double blind trial comparing prednisolone and 4-aminosalicylic acid enemas in acute distal ulcerative colitis.Sulphasalazine fails to prevent development of mucosal ulceration and 5-lipoxygenase activity in guinea-pigs with chronic inflammatory bowel disease induced by combined bacterial immunization and oral carrageenin.Effects of different doses of adrenocorticotrophic hormone on the serum lipoprotein profile in healthy subjects.Observational Study of Perspectives of Inflammatory Bowel Disease Patients Concerning the Use of Corticosteroids.Antioxidant effects of aminosalicylates and potential new drugs for inflammatory bowel disease: assessment in cell-free systems and inflamed human colorectal biopsies.
P2860
Q34563954-8D6CD8F0-ECF0-4E52-893C-AA58287A2DFFQ34723231-952DB9F0-4ADB-4F54-ABA7-EC6544BEBBC1Q35272521-931E98AB-D951-4D78-B4C6-0301DFD81D1EQ35501813-4E2E2FF2-87EC-427D-9D24-C01253A3746BQ35530728-A3B62F82-C8B5-4853-AF06-4E372A5BA132Q35558025-6D2C0587-7BB3-4E90-8467-95D03A16820DQ35799087-D97BA7FC-8206-49D9-B928-97F5442598E7Q38255794-A886F415-0ACF-4DDB-AB61-8AD490719F57Q40392345-1AA42D6D-4928-4B91-9C15-CBF8BAEF6AF6Q41193584-55BDEE86-CC5D-428B-A3A1-9357C12E51BEQ41818070-B69522BA-CC4E-4FF6-8ACA-5C123EBC5983Q41939253-AD912D47-56D0-4481-B585-D8D8A67351FCQ44995750-55652C4B-8228-4AA5-B4B9-C14938514D5BQ46517658-C4895734-BF10-46C7-860A-CBB04612C4C6Q46584512-DC83E8DD-825E-4E76-9D99-B8C7ED76C70AQ47652740-DB6BF39C-A2D7-4407-B667-341ADAF3A9AEQ54050412-00EA1C4A-51D8-4067-A73F-5566D057C9EE
P2860
Advances in drug therapy for inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advances in drug therapy for inflammatory bowel disease.
@en
Advances in drug therapy for inflammatory bowel disease.
@nl
type
label
Advances in drug therapy for inflammatory bowel disease.
@en
Advances in drug therapy for inflammatory bowel disease.
@nl
prefLabel
Advances in drug therapy for inflammatory bowel disease.
@en
Advances in drug therapy for inflammatory bowel disease.
@nl
P1476
Advances in drug therapy for inflammatory bowel disease.
@en
P2093
Peppercorn MA
P356
10.7326/0003-4819-112-1-50
P407
P577
1990-01-01T00:00:00Z